Genomic Health (GHDX) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income tax expense: 464K
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
Income tax expense: 464K
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.19), $0.05 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $80.9 million versus the consensus estimate of $78.12 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- RBC Capital Reiterates Outperform Rating on Lyft (LYFT), a post-earnings debrief with CFO
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
